Genistein Increases Epidermal Growth Factor Receptor Signaling and Promotes Tumor Progression in Advanced Human Prostate Cancer
Author Information
Author(s): Nakamura Hisae, Wang Yuwei, Kurita Takeshi, Adomat Hans, Cunha Gerald R., Wang Yuzhuo
Primary Institution: British Columbia Cancer Agency
Hypothesis
Does genistein promote metastasis in advanced prostate cancer?
Conclusion
Genistein treatment increases metastasis and cell proliferation while decreasing apoptosis in advanced prostate cancer.
Supporting Evidence
- Genistein-treated mice showed increased lymph node and secondary organ metastases compared to untreated controls.
- Immunohistological data indicated more proliferating and fewer apoptotic cancer cells in genistein-treated tumors.
- Genistein treatment resulted in enhanced phosphorylation of EGFR and Src tyrosine kinases.
Takeaway
Genistein, a compound found in soy, may actually help cancer grow instead of stopping it, especially in advanced prostate cancer.
Methodology
The study used a patient-derived prostate cancer xenograft model in immune-deficient mice to assess the effects of genistein on tumor progression.
Potential Biases
Potential bias in the selection of animal models and the interpretation of results based on the specific xenograft model used.
Limitations
The study's findings may not be applicable to all prostate cancer patients due to variability in individual responses to genistein.
Participant Demographics
The study involved male NOD-SCID mice grafted with human prostate cancer tissue.
Statistical Information
P-Value
p<0.004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website